Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Peripheral Nervous System Diseases 3Pain 3Breast Neoplasms 3Neurotoxicity Syndromes 2Colorectal Neoplasms 2Urinary Incontinence 1Prostatic Neoplasms 1Neoplasms 1Hematologic Neoplasms 1Emergence Delirium 1Cancer Pain 1CIPN 1Acute Pain 1

Interventions

Morphine 10Methadone 6Acetaminophen 5Oxycodone 4Lidocaine 4Fentanyl 4Ethanol 4Acupuncture Therapy 4Transcutaneous Electric Nerve Stimulation 3Buprenorphine 3Transcranial Direct Current Stimulation 2Surveys and Questionnaires 2Sodium Bicarbonate 2Radiosurgery 2Radiofrequency Ablation 2Pharmaceutical Services 2Ketamine 2Electroacupuncture 2Control Groups 2Analgesics, Opioid 2oxycodone naloxone combination 1nabiximols 1incobotulinumtoxinA 1Water 1Tramadol 1Therapeutic Touch 1Telemedicine 1Tapentadol 1Tablets 1Sugars 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Cancer Pain × Duloxetine Hydrochloride × Clear all
NCT05311774 2025-12-03

Efficacy of Duloxetine in Conjunction With Tramadol for Chronic Cancer Pain

Assiut University

Phase NA Completed
400 enrolled

Cancer Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡